Skip to main content
CARMAT logo

CARMAT — Investor Relations & Filings

Ticker · ALCAR ISIN · FR0010907956 LEI · 969500ARXACM0P0KH333 PA Manufacturing
Open in API
Filings indexed 570 across all filing types
Latest filing 2017-11-27 Regulatory Filings
Country FR France
Listing PA ALCAR

About CARMAT

https://www.carmatsa.com/en/

CARMAT is a medical technology company that designs, develops, and markets the Aeson® total artificial heart. This bioprosthetic device provides a therapeutic solution for patients suffering from end-stage biventricular heart failure. Aeson® is designed to replace the native heart, primarily as a bridge to transplantation for eligible patients. A key feature of the device is its self-regulation capability, which uses embedded sensors and biocompatible materials to automatically adapt blood flow based on the patient's physiological needs, thereby mimicking the function of a natural heart.

Recent filings

Filing Released Lang Actions
Communicated under the obligation to provide permanent information / Other communications
Regulatory Filings Classification · 1% confidence The document is explicitly titled 'PRESS RELEASE' and announces a specific operational milestone: the first implantation in the Czech Republic within the PIVOTAL clinical study framework. It details the location, the medical team, the study's purpose (CE marking), and future communication plans regarding the study's progress. This type of announcement, focusing on operational progress, clinical trial updates, and general company news outside of mandatory periodic financial filings (like 10-K or IR) or specific corporate actions (like dividends or management changes), is best classified as a general Regulatory Filing or Announcement. Since it is a press release detailing clinical trial progress and expansion, and it doesn't fit the specific definitions for ER, LTR, or CAP, the most appropriate general category is Regulatory Filings (RNS), which serves as a broad category for non-standard regulatory communications.
2017-11-27 English
Information relative au nombre total de droits de vote et d'actions composant le capital
Share Issue/Capital Change Classification · 1% confidence The document is a formal declaration dated November 15, 2017, detailing the total number of shares and voting rights (BRUT and NET) as of October 31, 2017. It explicitly references Article 223-16 of the AMF (Autorité des marchés financiers) general regulation. This type of filing, which reports changes in the total number of shares and voting rights, aligns most closely with notifications regarding capital structure changes or major shareholding notifications. Since it specifically details the total capital structure and voting rights, it is a mandatory regulatory disclosure related to the company's capital. Given the options, 'Share Issue/Capital Change' (SHA) is the most appropriate fit as it details the composition of the capital, including shares issued under a financing contract. It is not a general earnings release (ER) or a full annual report (10-K).
2017-11-15 French
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Regulatory Filings Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and announces a strategic partnership between CARMAT and AddUp regarding 3D printing technology to accelerate CARMAT's industrial phase. This type of announcement, detailing a business development, partnership, or strategic move, is typically classified as a general business update or regulatory filing. Since it is not a formal financial report (like 10-K, IR, ER), a specific shareholder action (like DIV, DVA), or a management change (MANG), it fits best under the general regulatory announcement category, RNS, as it is a material, non-financial operational update released to the public/market. The length (7930 chars) is substantial enough that it is the primary document, not just a brief announcement of another document (which would suggest RPA).
2017-11-13 French
Communicated under the obligation to provide permanent information / Other communications
Regulatory Filings Classification · 1% confidence The document is explicitly titled 'PRESS RELEASE' and announces a significant business event: 'CARMAT signs a partnership agreement with AddUp...'. This type of announcement, detailing strategic collaborations, business developments, or operational milestones outside of routine financial reporting (like earnings or annual reports), typically falls under general corporate news. Since it is not a formal regulatory filing like a 10-K, a specific financial report (IR, MRQ), or a management/board change (MANG), the most appropriate classification is the general regulatory/corporate announcement fallback, RNS, as it is a public disclosure of a material event. It is not a Report Publication Announcement (RPA) because it is the substance of the news, not just an announcement that a report is available.
2017-11-13 English
Communicated under the obligation to provide permanent information / Other communications
Regulatory Filings Classification · 1% confidence The document is explicitly titled 'PRESS RELEASE' and dated October 30, 2017. It announces a specific operational update: CARMAT receiving approval to perform implants in the Czech Republic for its PIVOTAL study. This type of announcement, detailing a specific, non-financial operational milestone or event, is characteristic of a general regulatory announcement or press release that doesn't fit the more specific categories like Earnings Release (ER), Capital Update (CAP), or Director's Dealing (DIRS). Since it is a formal announcement of a significant event (clinical trial expansion) and not a comprehensive report (like 10-K or IR), the most appropriate general category for such regulatory/corporate news that doesn't fit elsewhere is Regulatory Filings (RNS), which serves as a broad category for miscellaneous official announcements.
2017-10-30 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Regulatory Filings Classification · 1% confidence The document is explicitly titled "COMMUNIQUE DE PRESSE" (Press Release) and announces a specific operational update: CARMAT obtaining authorization to conduct PIVOT study implantations in the Czech Republic. It contains key highlights, quotes from management and a key physician, and general company background information. This format is characteristic of an initial announcement of material news, rather than a comprehensive periodic report (like 10-K or IR) or a transcript. Since it is an initial announcement of financial/operational results or material events, the most appropriate classification is Earnings Release (ER), even though the content is operational expansion rather than pure financial results, as ER often serves as the primary vehicle for significant operational news releases. However, given the content focuses entirely on clinical trial expansion and regulatory authorization, and not quarterly financial figures, it is a general corporate announcement. If the document were purely about financial results, ER would be perfect. Since it is a significant operational/clinical update announced via press release, and there isn't a specific code for 'Clinical Update Announcement', it falls best under the general announcement categories. Given the options, 'ER' (Earnings Release) is often used broadly for major periodic announcements, but 'RNS' (Regulatory Filings/General Regulatory Announcements) is a strong fallback for significant, non-standard announcements. Since this is a press release announcing a major step in a clinical study, and it is not a formal regulatory filing like a 10-K or a specific notice like DIV or DIRS, RNS is the most fitting general category for a significant, non-periodic corporate announcement that doesn't fit elsewhere. Revisiting the definitions: ER is for 'Initial announcement of quarterly/periodical financial results (key highlights only)'. This is not financial results. Therefore, RNS (General regulatory announcements and fallback category for miscellaneous filings) is the best fit for a significant press release detailing clinical/operational progress.
2017-10-30 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.